Lakewood-amedex Biotherapeutics Inc (LABT) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	752.93K	185.73K	182.15K	503.02K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.13M	525.17K	703.44K	3.29M
Operating expense	1.88M	712.06K	886.75K	3.79M
Total operating expenses	1.88M	712.06K	886.75K	3.79M
Operating income	-1.88M	-712.06K	-886.75K	-3.79M
Other non operating income	-	-	600.00	-
EBT including unusual items	-1.91M	-744.92K	-923.29K	-3.77M
EBT excluding unusual items	-1.91M	-744.92K	-923.29K	-3.77M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-1.91M	-744.92K	-923.29K	-3.77M
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	10.97K	4.95K	1.08K	28.28K
Interest expense	-37.81K	-37.81K	-38.22K	-10.63K
Net interest expenses	-26.84K	-32.86K	-37.14K	17.65K
Depreciation and amortization charges	1.16K	1.16K	1.16K	1.16K
EBITDA	-1.88M	-710.90K	-885.59K	-3.79M
Gain or loss from assets sale	-	-	-	-

Ask anything